BergströmJ., LindholmB.Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?Kidney Int Suppl1993; 40: S39–50.
2.
MarckmannP.Nutritional status of patients on hemodialysis and peritoneal dialysis.Clin Nephrol1988; 29: 75–8.
3.
YoungG.A., KoppleJ.D., LindholmB., VoneshE.F., DeVecchiA., ScalamognaA.Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study.Am J Kidney Dis1991; 17: 462–71.
4.
DaviesS.J., PhillipsL., GriffithsA.M., RusselL.H., NaishP.F., RusselG.I.What really happens to people on long-term peritoneal dialysis?Kidney Int1998; 54: 2207–17.
5.
JohanssonA., SamuelssonO., HaraldssonB., BosaeusJ., AttmanP-O. Body composition in patients treated with peritoneal dialysis.Nephrol Dial Transplant1998; 13: 1511–17.
6.
DaviesS.J., PhillipsL., GriffithsA.M., NaishP.F., RussellG.I.An analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients.Kidney Int2000; 57: 1743–54.
7.
StenvinkelP., LindholmB., LönnqvistF., KatzarskiK., HeimbürgerO.Increases in serum leptin during peritoneal dialysis are associated with inflammation and a decrease in lean body mass.J Am Soc Nephrol2000; (in press).
8.
Canada-U.S.A.(CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcome.J Am Soc Nephrol1996; 7: 198–207.
9.
McCuskerF.X., TeehanB.P., ThorpeK.E., KeshaviahP.R., ChurchillD. for the Canada-U.S.A. (CANUSA) Peritoneal Dialysis Study Group. How much dialysis is required for the maintenance of a good nutritional status.Kidney Int Suppl1996; 56: S56–61.
10.
AvramM.M., FeinP.A., BonominiL., MittmanN., LoutobyR., AvramD.K.Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study.Perit Dial Int1996; 16(Suppl 1): S190–4.
11.
StruijkD.G., KredietR.T., KoomenG.C.M., BoeschotenE.W., AriszL.The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival.Perit Dial Int1994; 14: 121–6.
12.
StenvinkelP., HeimbürgerO., LindholmB., KaysenG.A., BergströmJ.Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome).Nephrol Dial Transplant2000; (in press).
13.
YeunJ.Y., KaysenG.A.Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients.Am J Kidney Dis1997; 30: 923–7.
14.
OwenW.F., LowrieE.G.C-Reactive protein as an outcome predictor for maintenance hemodialysis patients.Kidney Int1998; 54: 627–36.
15.
ZimmermannJ., HerrlingerS., PruyA., MetzgerT., WannerC.Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.Kidney Int1999; 55: 648–58.
16.
HaubitzM., BrunkhorstR., WrengerE., FroeseP., SchulzeM., KochK.M.Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy.Perit Dial Int1996; 16: 158–62.
17.
RidkerP.M., CushmanM., StampferM.J., RussellP.T., HennekensC.H.Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men.N Engl J Med1997; 336: 973–9.
18.
BergströmJ., HeimbürgerO., LindholmB., QureshiA.R.Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients.J Am Soc Nephrol1995; 6: A573.
19.
IsekiK., TozawaM., YoshiS., FukiyamaK.Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients.Nephrol Dial Transplant1999; 14: 1956–60.
20.
NohH., LeeS.W., KangS.W., ShinS.K., ChoiK.H., LeeH.Y.Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients.Nephrol Dial Transplant1998; 18: 387–94.
21.
StenvinkelP., HeimbürgerO., PaultreF., DiczfalusyU., WangT., BerglundL.Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure.Kidney Int1999; 55: 1899–911.
PereiraB.J.G., ShapiroL., KingA.J., FalagasM.E., StromJ.A., DinarelloC.A.Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.Kidney Int1994; 45: 890–6.
24.
KimmelP.L., PhillipsT.M., SimmensS.J., PetersonR.A., WeihsK.L., AlleyneS.Immunologic function and survival in hemodialysis patients.Kidney Int1998; 54: 236–44.
25.
BergströmJ., LindholmB.Malnutrition, cardiac disease and mortality — an integrated point of view.Am J Kidney Dis1998; 32: 834–41.
26.
Plata-SalamánC.R.Cytokines and anorexia: A brief overview.Semin Oncol1998; 25: 64–72.
27.
BologaR.M., LevineD.M., ParkerT.S., CheighJ.S., SeurD., StenzelK.H.Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.Am J Kidney Dis1998; 32: 107–14.
28.
KimH., BologaR., ParkerT., LevineD., CheichJ.S., StenzelK.Serum IL-6 level as an indicator of survival outcome in CAPD patients.J Am Soc Nephrol1999; 10: A1248.
29.
KoppleJ., BernardD., MessanaJ., SwartzR., BergströmJ., LindholmB.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 1148–57.
30.
FouqueD., PengS.C., ShamirE., KoppleJ.D.Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients.Kidney Int2000; 57: 646–54.
31.
EricssonF., DivinoJ.D., LindgrenB.Low grade inflammatory activity abolishes the anabolic effect of growth hormone (GH) on metabolism in hemodialysis patients.J Am Soc Nephrol1999; 10: A162.
32.
ElliotM.J., MainiR.N., FeldmannM., KaldenJ.R., AntoniC., SmolenJ.S.Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.Lancet1994; 344: 1105–10.
33.
Reyes-TeránG., Sierra-MaderoJ.G., Martínez del CerroV., Arroyo-FigueroaH., PasquettiA., CalvaJ.J.Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double blind, placebo-controlled clinical study.AIDS1996; 10: 1501–7.
34.
HylanderB., BarkelingB., RössnerS.Eating behavior in continuous ambulatory dialysis and hemodialysis patients.Am J Kidney Dis1992; 6: 592–7.
35.
LindholmB., WangT., HeimbürgerO., BergströmJ.Influence of different treatment and schedules on the factors conditioning the nutritional status in dialysis patients.Nephrol Dial Transplant1998; 13(Suppl 6): 66–73.
36.
YoungG.A., WoodrowG., KendallS., OldroydB., TurneyJ.H., BrownjohnA.M.Increased plasma leptin/fat ratio in patients with chronic renal failure: A cause of malnutrition.Nephrol Dial Transplant1997; 12: 2318–23.
37.
OdamakiM., FuruyaR., YoneyamaT., NishikinoM., HibiI., MiyajiK.Association of the serum leptin concentration with weight loss in chronic hemodialysis patients.Am J Kidney Dis1999; 33: 361–8.
ParryR.G., JohnsonD.W., CareyD.G., HibbinsM., ChangW., PurdieW.Serum leptin correlates with fat mass but not energy intake in continuous ambulatory peritoneal dialysis.Perit Dial Int1998; 18: 569–75.
40.
FernströmA., HylanderB., MoritzÅ, JacobssonH., RössnerS.Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis.Perit Dial Int1998; 18: 166–71.
41.
NordforsL., HeimbürgerO., LönnqvistF., LindholmB., HelmrichJ., SchallingM.Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2.Kidney Int2000; 57: 1713–19.
42.
CalleE.E., ThunM.J., PetrelliJ.M., RodriguezC., HeathC.W.Body-mass index and mortality in a prospective cohort of US adults.N Engl J Med1999; 341: 1097–105.
43.
FleischmannE., TealN., DudleyJ., MayW., BowerJ.D., SalahudeenA.K.Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients.Kidney Int1999; 55: 1560–7.
44.
KoppleJ.D., ZhuX., LewN.L., LowrieE.G.Body weight-for-height relationships predict mortality and morbidity in maintenance hemodialysis patients.Kidney Int1999; 56: 1136–48.
45.
JohnsonD.W., HerzigK.A., PurdieD., ChangW., BrownA., CampbellS.B.Obesity is a favorable prognostic factor in peritoneal dialysis patients.J Am Soc Nephrol1999; 10: A1241.